Published by Benjamin Chiou on 8th February 2024
(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.
URL: http://www.digitallook.com/dl/news/story/34077863/...